Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
101140.KS Stock Summary
In the News
101140.KS Financial details
Company Rating
Buy
Market Cap
4.67B
Income
20.29B
Revenue
7.92B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
2.27
Forward P/E
-
PEG
-0.28
P/S
0.59
P/B
0.31
P/C
-
P/FCF
-0.5
Quick Ratio
-
Current Ratio
5.91
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
319.17
EPS next Y
-
EPS next Q
-
EPS this Y
-194.15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
8.55%
Revenue Q/Q
-34.65%
EPS Q/Q
188.61%
-
-
-
-
SMA20
-
SMA50
-
SMA100
1900%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
16%
ROC
0.27%
Gross Margin
23%
Oper. Margin
517%
Profit Margin
256%
Payout
-
Shs Outstand
9.99M
Shs Float
842.35K
-
-
-
-
Target Price
-
52W Range
462.0-2650.0
52W High
+252.45%
52W Low
+1921.65%
RSI
100
Rel Volume
-
Avg Volume
271.77K
Volume
Perf Week
0%
Perf Month
0%
Perf Quarter
1900%
Perf Half Y
1900%
-
-
-
-
Beta
1.032
-
-
Volatility
0%, 0%
Prev Close
0%
Price
9340
Change
0%
101140.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 329.99 | 306.01 | 247.07 | 195.2 | 157.25 | |
Net income per share | 72.58 | 850.81 | -1.09K | 1.75K | -1.65K | |
Operating cash flow per share | -74.09 | -119.59 | -194.24 | -131.66 | -158.65 | |
Free cash flow per share | -74.09 | -132.58 | -217.72 | -176.39 | -163.21 | |
Cash per share | 908.35 | 876.06 | 1.91K | 431.18 | 128.1 | |
Book value per share | 1.02K | 2.06K | 1.88K | 3.32K | 1.44K | |
Tangible book value per share | 1.02K | 2.06K | 1.87K | 3.31K | 1.43K | |
Share holders equity per share | 1.02K | 2.06K | 1.88K | 3.32K | 1.44K | |
Interest debt per share | 0 | 441.81 | 266.09 | 321.08 | 75.36 | |
Market cap | 117.39B | 95.55B | 216.7B | 191.15B | 56.56B | |
Enterprise value | 116.78B | 97.39B | 212.36B | 181.41B | 49.05B | |
P/E ratio | 70.55 | 3.51 | -4.81 | 2.03 | -0.47 | |
Price to sales ratio | 15.52 | 9.75 | 21.21 | 18.24 | 4.96 | |
POCF ratio | -69.1 | -24.96 | -26.98 | -27.04 | -4.92 | |
PFCF ratio | -69.1 | -22.51 | -24.07 | -20.18 | -4.78 | |
P/B Ratio | 5.03 | 1.45 | 2.78 | 1.07 | 0.54 | |
PTB ratio | 5.03 | 1.45 | 2.78 | 1.07 | 0.54 | |
EV to sales | 15.43 | 9.94 | 20.78 | 17.31 | 4.3 | |
Enterprise value over EBITDA | 77.25 | -133.16 | -8.54 | -47.18 | 1.08 | |
EV to operating cash flow | -68.74 | -25.44 | -26.44 | -25.66 | -4.26 | |
EV to free cash flow | -68.74 | -22.95 | -23.59 | -19.15 | -4.14 | |
Earnings yield | 0.01 | 0.29 | -0.21 | 0.49 | -2.12 | |
Free cash flow yield | -0.01 | -0.04 | -0.04 | -0.05 | -0.21 | |
Debt to equity | 0 | 0.15 | 0.06 | 0.08 | 0.02 | |
Debt to assets | 0 | 0.11 | 0.05 | 0.05 | 0.01 | |
Net debt to EBITDA | -0.41 | -2.51 | 0.17 | 2.53 | -0.17 | |
Current ratio | 37.65 | 1.34 | 4.73 | 0.41 | 0.47 | |
Interest coverage | 0 | -0.5 | -0.87 | -2.01 | 11.93 | |
Income quality | -1.02 | -0.29 | 0.18 | -0.08 | 0.1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.04 | 0.1 | 0.16 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0.01 | 0 | 0 | |
Capex to operating cash flow | 0 | 0.11 | 0.12 | 0.34 | 0.03 | |
Capex to revenue | 0 | -0.04 | -0.1 | -0.23 | -0.03 | |
Capex to depreciation | 0 | -1.63 | -2.19 | -2.15 | -0.23 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.29K | 6.28K | 6.8K | 11.44K | 7.31K | |
ROIC | 0.07 | -0.06 | -0.06 | -0.03 | 0.36 | |
Return on tangible assets | 0.07 | 0.3 | -0.47 | 0.34 | -0.85 | |
Graham Net | 903.78 | 189.6 | 1.57K | -1.25K | -316.94 | |
Working capital | 23.32B | 8.38B | 67.71B | -45.87B | -19.33B | |
Tangible asset value | 23.35B | 65.87B | 77.37B | 177.56B | 103.9B | |
Net current asset value | 22.99B | 7.76B | 66.87B | -64.55B | -20.37B | |
Invested capital | 0 | 0.15 | 0.06 | 0.08 | 0.02 | |
Average receivables | 0 | 1.26B | 4.16B | 6.37B | 6.38B | |
Average payables | 603.97M | 430.04M | 495.87M | 602.43M | 477.46M | |
Average inventory | 1.4B | 1.93B | 1.57B | 1.25B | 1.51B | |
Days sales outstanding | 0 | 93.65 | 207.17 | 241.87 | 186.08 | |
Days payables outstanding | 23.07 | 18.12 | 21.68 | 27.67 | 12.75 | |
Days of inventory on hand | 93.31 | 89.09 | 39.33 | 63.47 | 63.25 | |
Receivables turnover | 0 | 3.9 | 1.76 | 1.51 | 1.96 | |
Payables turnover | 15.82 | 20.15 | 16.83 | 13.19 | 28.63 | |
Inventory turnover | 3.91 | 4.1 | 9.28 | 5.75 | 5.77 | |
ROE | 0.07 | 0.41 | -0.58 | 0.53 | -1.15 | |
Capex per share | 0 | -13 | -23.48 | -44.73 | -4.56 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 34.92 | 34.19 | 28.85 | 13.38 | 0 | |
Net income per share | -96.13 | -58.93 | 269.29 | 28 | 0 | |
Operating cash flow per share | -7.65 | -106 | -7.14 | -3.22 | 0 | |
Free cash flow per share | -8.63 | -106.31 | -7.14 | -3.22 | 0 | |
Cash per share | 113.87 | 128.1 | 120.11 | 43.86 | 0 | |
Book value per share | 595.33 | 1.44K | 1.64K | 981.92 | 0 | |
Tangible book value per share | 587.77 | 1.43K | 1.64K | 979.07 | 0 | |
Share holders equity per share | 595.33 | 1.44K | 1.64K | 981.92 | 0 | |
Interest debt per share | 108.87 | 32.7 | 28.18 | 5.4 | 0 | |
Market cap | 91.58B | 56.56B | 33.87B | 70.57B | 0 | |
Enterprise value | 90.19B | 49.05B | 27.04B | 64.68B | 0 | |
P/E ratio | -3.26 | -3.31 | 0.43 | 4.17 | 0 | |
Price to sales ratio | 35.94 | 22.82 | 16.19 | 34.89 | 0 | |
POCF ratio | -164.14 | -7.36 | -65.43 | -144.84 | 0 | |
PFCF ratio | -145.34 | -7.34 | -65.43 | -144.84 | 0 | |
P/B Ratio | 2.11 | 0.54 | 0.28 | 0.48 | 0 | |
PTB ratio | 2.11 | 0.54 | 0.28 | 0.48 | 0 | |
EV to sales | 35.4 | 19.78 | 12.92 | 31.98 | 0 | |
Enterprise value over EBITDA | 21.94 | 1.4 | 2.79 | 110.61 | 0 | |
EV to operating cash flow | -161.65 | -6.38 | -52.24 | -132.76 | 0 | |
EV to free cash flow | -143.13 | -6.36 | -52.24 | -132.76 | 0 | |
Earnings yield | -0.08 | -0.08 | 0.58 | 0.06 | 0 | |
Free cash flow yield | -0.01 | -0.14 | -0.02 | -0.01 | 0 | |
Debt to equity | 0.16 | 0.02 | 0.02 | 0 | 0 | |
Debt to assets | 0.06 | 0.01 | 0.01 | 0 | 0 | |
Net debt to EBITDA | -0.34 | -0.21 | -0.7 | -10.07 | 0 | |
Current ratio | 0.25 | 0.47 | 0.67 | 5.92 | 5.91 | |
Interest coverage | 3.7 | 58.05 | 58.62 | -18.67 | 0 | |
Income quality | 0.02 | -0.52 | -0.04 | -0.12 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.2 | 0.15 | 0.19 | 0.99 | 1.58 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.13 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.03 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | -0.23 | -0.06 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.13K | 1.38K | 3.16K | 786.52 | 0 | |
ROIC | 0.02 | -0.09 | 0.1 | -0.01 | -0.01 | |
Return on tangible assets | -0.06 | -0.03 | 0.14 | 0.03 | 0.01 | |
Graham Net | -881.74 | -316.94 | -158.24 | 49.25 | 0 | |
Working capital | -59.77B | -19.33B | -8.03B | 11.39B | 10.68B | |
Tangible asset value | 42.89B | 103.9B | 118.73B | 147.94B | 149.03B | |
Net current asset value | -60.7B | -20.37B | -8.97B | 9.85B | 8.7B | |
Invested capital | 0.16 | 0.02 | 0.02 | 0 | 0 | |
Average receivables | 8.95B | 7.39B | 5.67B | 5.35B | 2.59B | |
Average payables | 497.53M | 388.01M | 384.8M | 357.81M | 127.41M | |
Average inventory | 1.86B | 1.76B | 1.53B | 1.57B | 801.17M | |
Days sales outstanding | 316.53 | 211.06 | 237.68 | 230.13 | 0 | |
Days payables outstanding | 23.89 | 12.52 | 27.59 | 15.95 | 0 | |
Days of inventory on hand | 101.45 | 62.12 | 92.01 | 100.31 | 0 | |
Receivables turnover | 0.28 | 0.43 | 0.38 | 0.39 | 0 | |
Payables turnover | 3.77 | 7.19 | 3.26 | 5.64 | 0 | |
Inventory turnover | 0.89 | 1.45 | 0.98 | 0.9 | 0 | |
ROE | -0.16 | -0.04 | 0.16 | 0.03 | 0.01 | |
Capex per share | -0.99 | -0.31 | 0 | 0 | 0 |
101140.KS Frequently Asked Questions
What is INBIOGEN CO.,Ltd stock symbol ?
INBIOGEN CO.,Ltd is a KR stock and trading under the symbol 101140.KS
What is INBIOGEN CO.,Ltd stock quote today ?
INBIOGEN CO.,Ltd stock price is $9340 today.
Is INBIOGEN CO.,Ltd stock public?
Yes, INBIOGEN CO.,Ltd is a publicly traded company.